CHERYL JONES: Open Payments
NPI 1679585434 · RALEIGH, NC. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$878 in 34 payments from 12 companies in 2025. Trend: 2023 $46 · 2024 $0 · 2025 $878
Food & beverage: $878
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 9 | $218 |
| Novartis Pharmaceuticals Corporation | 3 | $120 |
| Regeneron Healthcare Solutions, Inc. | 4 | $115 |
| Janssen Biotech, Inc. | 4 | $86 |
| SUN PHARMACEUTICAL INDUSTRIES INC. | 4 | $81 |
| KYOWA KIRIN, INC. | 2 | $48 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 2 | $47 |
| UCB, Inc. | 2 | $44 |
| GENZYME CORPORATION | 1 | $38 |
| REVANCE THERAPEUTICS, INC. | 1 | $36 |
Products named: SKYRIZI, DUPIXENT, Rhapsido, TREMFYA, ILUMYA, POTELIGEO, Bimzelx, RINVOQ.
Industry payments across NC — which companies pay providers there.
